Editorial
doi: 10.1007/s11912-003-0014-x.
Randomized trials in oncology: a fertile ground for controversy
- PMID: 12895382
- DOI: 10.1007/s11912-003-0014-x
Item in Clipboard
Editorial
Randomized trials in oncology: a fertile ground for controversy
Curr Oncol Rep.
2003 Sep.
No abstract available
Similar articles
-
Looking for efficiency rather than efficacy in randomized controlled trials in oncology.Ann Oncol. 2010 Jul;21(7):1391-1393. doi: 10.1093/annonc/mdq266. Epub 2010 May 25. Ann Oncol. 2010. PMID: 20501504 No abstract available.
-
Stopping a trial early in oncology: for patients or for industry?Ann Oncol. 2009 Feb;20(2):395-6. doi: 10.1093/annonc/mdn753. Epub 2009 Jan 15. Ann Oncol. 2009. PMID: 19150952 No abstract available.
-
Phase III trials in oncology: setting standards of care?Nat Clin Pract Oncol. 2005 Sep;2(9):426-7. doi: 10.1038/ncponc0284. Nat Clin Pract Oncol. 2005. PMID: 16264993 No abstract available.
-
Early integration of palliative care into oncology: evidence, challenges and barriers.Ann Palliat Med. 2015 Jul;4(3):122-31. doi: 10.3978/j.issn.2224-5820.2015.07.03. Ann Palliat Med. 2015. PMID: 26231808 Review.
-
Placebo effects in oncology.J Natl Cancer Inst. 2003 Jan 1;95(1):19-29. doi: 10.1093/jnci/95.1.19. J Natl Cancer Inst. 2003. PMID: 12509397 Review.
Cited by
-
The use of a predictive statistical model to make a virtual control arm for a clinical trial.PLoS One. 2019 Sep 4;14(9):e0221336. doi: 10.1371/journal.pone.0221336. eCollection 2019. PLoS One. 2019. PMID: 31483824 Free PMC article.